https://www.thebody.com/content/art12773.html
AIDSinfo logo

HIVinfo

HIVinfo.nih.gov offers access to the latest, federally approved HIV/AIDS medical practice guidelines, HIV treatment and prevention clinical trials, and other research information for health care providers, researchers, people affected by HIV/AIDS, and the general public.

HIVinfo.nih.gov, a service of the U.S. Department of Health and Human Services (HHS), is maintained by the Office of AIDS Research (OAR), which is part of the National Institutes of Health (NIH). OAR coordinates HIV/AIDS research across the National Institutes of Health (NIH). The NIH provides the largest public investment in HIV/AIDS research globally.

HIVinfo.nih.gov is 100% federally funded and sponsored by the Office of AIDS Research (OAR).

[Editor's Note from TheBody: This information has been cross-posted from HIVinfo's "About" page]

Latest by HIVinfo

aging face
Reference

HIV and Older People

Anyone can get HIV, including older people, HIVinfo reports in this fact sheet. According to the CDC, in 2016, nearly half of the people in the United States living with diagnosed HIV were aged 50 and older.

By HIVinfo
concept illustration: medicine, healthcare, health control, medical equipment
Reference

How to Find HIV Treatment Services

If you're living with HIV in the U.S., this federal government fact sheet provides a brief breakdown of options that can help you find a health care provider, pay for your medicines, locate affordable housing, and get help with mental health issues.

By HIVinfo
HIV Treatment Adherence Img

HIV Treatment Adherence

Treatment adherence includes starting HIV treatment, keeping all medical appointments, and taking HIV medicines every day as prescribed. For people with HIV, treatment adherence is key to staying healthy.

By HIVinfo
HIV Medicines and Side Effects Img

HIV Medicines and Side Effects

Key PointsHIV medicines help people with HIV live longer, healthier lives. Sometimes HIV medicines can also cause side effects. Most side effects from HIV medicines are manageable, but a few can be serious.Overall, the benefits of HIV medicines far o...

By HIVinfo
An Overview of Valproic Acid Img

An Overview of Valproic Acid

Other Names: Depakene, Depakote, Depakote ER, Epival, VPA, divalproex sodium, valproate Drug Class: Latency-Reversing Agents Molecular Formula: C8 H16 O2 Registry Number: 99-66-1 (CAS) Chemical Name: 2-propylpentanoic acid Chemical Class: O...

By HIVinfo
An Overview of Kaletra (Lopinavir/Ritonavir) Img

An Overview of Kaletra (Lopinavir/Ritonavir)

Brand Name: Kaletra Other Name(s): LPV / RTV, LPV/r, ritonavir-boosted lopinavir Drug Class: Protease Inhibitors

By HIVinfo
An Overview of Isentress (Raltegravir) Img

An Overview of Isentress (Raltegravir)

Brand Name: Isentress Other Name(s): RAL, raltegravir potassium Drug Class: Integrase Inhibitors

By HIVinfo
An Overview of Prezista (Darunavir) Img

An Overview of Prezista (Darunavir)

Brand Name: Prezista Other Name(s): DRV, darunavir ethanolate Drug Class: Protease Inhibitors

By HIVinfo
An Overview of Epzicom (Abacavir/3TC, Kivexa) Img

An Overview of Epzicom (Abacavir/3TC, Kivexa)

Brand Name: Epzicom Other Name(s): ABC/3TC, abacavir sulfate/lamivudine Drug Class: Nucleoside Reverse Transcriptase Inhibitors

By HIVinfo
An Overview of Atripla (Efavirenz/Tenofovir/FTC) Img

An Overview of Atripla (Efavirenz/Tenofovir/FTC)

Brand Name: Atripla Other Name(s): EFV/FTC/TDF, efavirenz/emtricitabine/tenofovir DF Drug Class: Combination Drugs

By HIVinfo